Login / Signup

Pten knockout affects drug resistance differently in melanoma and kidney cancer.

Klaudia K BrodaczewskaAleksandra MajewskaAleksandra Filipiak-DulibanClaudine Kieda
Published in: Pharmacological reports : PR (2023)
The results confirmed heterogenous cell responses to PTEN loss, which may lead to a better understanding of the role of PTEN in particular types of tumors and points to PTEN as a therapeutic target for personalized medicine.
Keyphrases
  • pi k akt
  • cell proliferation
  • signaling pathway
  • papillary thyroid
  • single cell
  • cell therapy